Elite Pharmaceuticals Inc (ELTP:OTC) Annual Reports & Investor Relations Material

Overview

Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that has its hands in both Abbreviated New Drug Applications for Generic Products and New Drug Applications for Branded Products segments. The company prides itself on the development and manufacture of oral, controlled-release products and generic pharmaceuticals. Elite Pharmaceuticals, Inc. owns, licenses, and contract-manufactures various generic and oral dose pharmaceuticals products that treat an array of illnesses ranging from cardiovascular diseases to muscle relaxants. Additionally, the company manufactures controlled-release products on a contract basis for third parties in the areas of pain, allergy, bariatric, and infection. Elite Pharmaceuticals, Inc. is further looking to develop abuse deterrent opioid products. The company is headquartered in Northvale, New Jersey, and was incorporated in 1997.

Frequently Asked Questions

What is Elite Pharmaceuticals Inc's ticker?

Elite Pharmaceuticals Inc's ticker is ELTP

What exchange is Elite Pharmaceuticals Inc traded on?

The company's shares trade on the OTC stock exchange

Where are Elite Pharmaceuticals Inc's headquarters?

They are based in Northvale, New Jersey

How many employees does Elite Pharmaceuticals Inc have?

There are 11-50 employees working at Elite Pharmaceuticals Inc

What is Elite Pharmaceuticals Inc's website?

It is elitepharma.com/welcome

What type of sector is Elite Pharmaceuticals Inc?

Elite Pharmaceuticals Inc is in the Healthcare sector

What type of industry is Elite Pharmaceuticals Inc?

Elite Pharmaceuticals Inc is in the Drug Manufacturers - Other industry

Who are Elite Pharmaceuticals Inc's peers and competitors?

The following five companies are Elite Pharmaceuticals Inc's industry peers:

- PetIQ

- Amryt Pharma plc

- MYOS RENS Technology Inc.

- Bausch Health

- N4 Pharma Plc